REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 36 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $11,000 | +450.0% | 21,186 | +42.1% | 0.00% | – |
Q4 2016 | $2,000 | -91.3% | 14,906 | -86.6% | 0.00% | -100.0% |
Q3 2016 | $23,000 | -48.9% | 111,386 | -38.4% | 0.00% | 0.0% |
Q2 2016 | $45,000 | -15.1% | 180,876 | +13.1% | 0.00% | 0.0% |
Q1 2016 | $53,000 | +1.9% | 159,977 | +11.8% | 0.00% | 0.0% |
Q4 2015 | $52,000 | -43.5% | 143,107 | -18.9% | 0.00% | -50.0% |
Q3 2015 | $92,000 | +8.2% | 176,453 | +26.2% | 0.00% | 0.0% |
Q2 2015 | $85,000 | +750.0% | 139,787 | +939.3% | 0.00% | – |
Q1 2015 | $10,000 | -95.9% | 13,450 | -96.1% | 0.00% | -100.0% |
Q4 2014 | $243,000 | +268.2% | 346,822 | +325.4% | 0.00% | +300.0% |
Q3 2014 | $66,000 | +247.4% | 81,537 | +276.3% | 0.00% | – |
Q2 2014 | $19,000 | -94.3% | 21,668 | -92.9% | 0.00% | -100.0% |
Q1 2014 | $331,000 | +903.0% | 305,764 | +317.8% | 0.00% | – |
Q3 2013 | $33,000 | – | 73,176 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 2,250,840 | $1,013,000 | 0.07% |
Benin Management CORP | 83,000 | $38,000 | 0.02% |
WFG Advisors, LP | 20,000 | $9,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 40,230 | $19,000 | 0.00% |
UBS AG | 1,000 | $0 | 0.00% |
NOMURA HOLDINGS INC | 137,100 | $62,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 276,931 | $125,000 | 0.00% |
GUGGENHEIM CAPITAL LLC | 39,286 | $18,000 | 0.00% |
Commonwealth Equity Services, Inc | 33,339 | $15,000 | 0.00% |
Citadel Advisors | 42,132 | $19,000 | 0.00% |